Showing 1 - 1 of 1
News, Apinya Wipatayotin, Published on 13/07/2020
» CU-Cov19 -- a novel coronavirus vaccine being developed by a Thai research team in collaboration with the University of Pennsylvania -- is expected to enter mass production by the end of the third quarter next year, the research team said on Sunday.